ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2.
Iwanaga N, Cooper L, Rong L, Maness NJ, Beddingfield B, Qin Z, Crabtree J, Tripp RA, Yang H, Blair R, Jangra S, García-Sastre A, Schotsaert M, Chandra S, Robinson JE, Srivastava A, Rabito F, Qin X, Kolls JK.
Iwanaga N, et al. Among authors: tripp ra.
iScience. 2022 Jan 21;25(1):103670. doi: 10.1016/j.isci.2021.103670. Epub 2021 Dec 20.
iScience. 2022.
PMID: 34957381
Free PMC article.